Isolated Executive Impairment and Associated Frontal Neuropathology

Cognitive impairment in the absence of dementia is common in elderly individuals and is most often studied in the context of an isolated impairment in memory. In the current study, we report the neuropsychological and neuropathological features of a nondemented elderly individual with isolated impairment on a test of executive function (i.e., Trail Making Test) and preserved memory, language, and visuospatial function. Postmortem studies indicated that cortical neurofibrillary tangles (NFT) varied considerably, and some regions contained large numbers of neuritic senile plaques. Semiquantitative immunohistochemistry showed higher NFT and amyloid-beta (Aβ) loads in the frontal cortex relative to the temporal, entorhinal, occipital, and parietal cortices. A survey of the entire cingulate gyrus showed a wide dispersion of Aβ42 with the highest concentration in the perigenual part of the anterior cingulate cortex; Aβ appeared to be linked with neuron loss and did not overlap with the heaviest neuritic degeneration. The current case may represent a nonmemory presentation of mild cognitive impairment (executive mild cognitive impairment) that is associated with frontal and anterior cingulate pathology and may be an early stage of the frontal variant of Alzheimer disease.

[1]  A Brun,et al.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. , 1987, Archives of gerontology and geriatrics.

[2]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.

[3]  M. Singleton The Human Nervous System, ed 2 , 1976 .

[4]  C. Filley Diagnosis of Alzheimer's disease. , 1988, Colorado medicine.

[5]  A. Dugbartey,et al.  Neuropsychological assessment of executive functions. , 1999, Seminars in clinical neuropsychiatry.

[6]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[7]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[8]  L. Gustafson Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis , 1998 .

[9]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[10]  L. Gustafson,et al.  Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. , 1987, Archives of gerontology and geriatrics.

[11]  A. Brun,et al.  Frontal lobe degeneration of non‐Alzheimer type , 1992, Bailliere's clinical neurology.

[12]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[13]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[14]  Y. Ihara,et al.  Alzheimer β Amyloid Deposition Enhanced by ApoE ϵ4 Gene Precedes Neurofibrillary Pathology in the Frontal Association Cortex of Nondemented Senior Subjects , 2001 .

[15]  C. Cotman,et al.  Clinical and pathological evidence for a frontal variant of Alzheimer disease. , 1999, Archives of neurology.

[16]  Brent A. Vogt,et al.  Multivariate Analysis of Laminar Patterns of Neurodegeneration in Posterior Cingulate Cortex in Alzheimer's Disease , 1998, Experimental Neurology.

[17]  B. Vogt,et al.  Patterns of Cortical Neurodegeneration in Alzheimer's Disease: Subgroups, Subtypes, and Implications for Staging Strategies , 2001 .

[18]  B. Vogt,et al.  Multifocal Cortical Neurodegeneration in Alzheimer’s Disease , 1999 .

[19]  Y. Ihara,et al.  Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects. , 2001, Journal of neuropathology and experimental neurology.

[20]  J. Dickens,et al.  Prevalence of cognitive impairment: Data from the Indianapolis Study of Health and Aging , 2001 .

[21]  Z. Khachaturian Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.